117 related articles for article (PubMed ID: 2491469)
1. Human gastric acid secretion following repeated doses of AG-1749.
Müller P; Dammann HG; Leucht U; Simon B
Aliment Pharmacol Ther; 1989 Apr; 3(2):193-8. PubMed ID: 2491469
[TBL] [Abstract][Full Text] [Related]
2. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
[TBL] [Abstract][Full Text] [Related]
3. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Nagaya H; Inatomi N; Satoh H
Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288
[TBL] [Abstract][Full Text] [Related]
4. Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers.
Müller P; Göksu MA; Fuchs W; Schlüter F; Simon B
Aliment Pharmacol Ther; 2000 Sep; 14(9):1225-9. PubMed ID: 10971240
[TBL] [Abstract][Full Text] [Related]
5. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers.
Bruley des Varannes S; Levy P; Lartigue S; Dellatolas F; Lemaire M; Galmiche JP
Aliment Pharmacol Ther; 1994 Jun; 8(3):309-14. PubMed ID: 7918926
[TBL] [Abstract][Full Text] [Related]
6. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
Takeda H; Hokari K; Asaka M
J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
[TBL] [Abstract][Full Text] [Related]
8. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
Howden CW; Forrest JA; Reid JL
Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
[TBL] [Abstract][Full Text] [Related]
9. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers.
Bell NJ; Hunt RH
Aliment Pharmacol Ther; 1996 Dec; 10(6):897-904. PubMed ID: 8971286
[TBL] [Abstract][Full Text] [Related]
10. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG
Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224
[TBL] [Abstract][Full Text] [Related]
12. Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers.
Bell N; Karol MD; Sachs G; Greski-Rose P; Jennings DE; Hunt RH
Aliment Pharmacol Ther; 2001 Jan; 15(1):105-13. PubMed ID: 11136283
[TBL] [Abstract][Full Text] [Related]
13. The effects of oral doses of lansoprazole and omeprazole on gastric pH.
Tolman KG; Sanders SW; Buchi KN; Karol MD; Jennings DE; Ringham GL
J Clin Gastroenterol; 1997 Mar; 24(2):65-70. PubMed ID: 9077718
[TBL] [Abstract][Full Text] [Related]
14. Dose ranging study of lansoprazole, a new proton pump inhibitor, in patients with high gastric acid secretion.
Berlin I; Molinier P; Duchier A; Cournot A; Durrel J; Dellatolas F; Duchier J
Eur J Clin Pharmacol; 1992; 43(2):117-9. PubMed ID: 1425865
[TBL] [Abstract][Full Text] [Related]
15. [Comparative efficacy of lansoprazole and omeprazole on the intragastric pH measured over a period of 24 hours and on the basal].
Paul G; Ramdani A; Mignon M; Vallot T; Forestier S; Cadiot G; Ruszniewski P; Joubert-Collin M
Gastroenterol Clin Biol; 1994; 18(8-9):695-701. PubMed ID: 7875436
[TBL] [Abstract][Full Text] [Related]
16. Gastric antisecretory activity of lansoprazole in different experimental models: comparison with omeprazole.
Coruzzi G; Adami M; Bertaccini G
Gen Pharmacol; 1995 Sep; 26(5):1027-32. PubMed ID: 7557245
[TBL] [Abstract][Full Text] [Related]
17. [Behavior of acid secretion under the long-term daily administration of omeprazol].
Dammann HG; Müller P; Seitz HK; Simon B
Schweiz Med Wochenschr; 1983 Jun; 113(24):895-8. PubMed ID: 6348940
[TBL] [Abstract][Full Text] [Related]
18. Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
Simon B; Müller P; Marinis E; Lühmann R; Huber R; Hartmann R; Wurst W
Aliment Pharmacol Ther; 1990 Aug; 4(4):373-9. PubMed ID: 2151747
[TBL] [Abstract][Full Text] [Related]
19. Lansoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
Dammann HG; Fuchs W; Richter G; Burkhardt F; Wolf N; Walter TA
Aliment Pharmacol Ther; 1997 Apr; 11(2):359-64. PubMed ID: 9146776
[TBL] [Abstract][Full Text] [Related]
20. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
Mignon M; Hochlaf S; Forestier S; Ruszniewski P; Vatier J; Joubert-Collin M
Gastroenterol Clin Biol; 1994; 18(1):13-6. PubMed ID: 8187984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]